The
Breast Localization Wire Market is expected to witness lucrative growth on
account of the increasing demand of diagnostic and screening techniques for
detecting breast cancer. Breast cancer is one of the common cancer type by
which women are affected worldwide and thus represents more than a quarter of
all cancer deaths in women. It is the major cause of mortality in women
worldwide. The market is divided into ultrasound, mammography, MRI, and others
(thermography and PET). However, contemporarily digital mammography considered
as a standard technique for screening breast cancer mainly due to time taken
for the procedure, cost, sensitivity in conducting tests, and expertise
required in carrying out the procedure. It is a technique to detect breast tissues
that are present with malignant tumor. Malignant tumor is cancerous and is
primarily made up of cells that grow out of control. Mammography uses low
energy X-rays to screen the early detection of breast cancer, thus making it an
important tool for the cure.
Growing
awareness, and increase in the number of aged females are few factors that are
expected to fuel the market growth over the forecasted period. Globally,
countries that constitutes to have highest breast cancer cases out of 100,000
women are Belgium, Denmark, France, Israel, Iceland, Ireland, Uruguay, Finland,
the UK, Australia, Canada, Luxembourg, New Zealand, and the US. Key market
drivers that propel the growth of digital mammography are high prevalence of
breast cancer, parallel rise in mammograms, growing significance of systematic
early detection, rise in popularity of 3D mammography, and prominence of
computer aided detection (CAD). Changing lifestyle, government sponsored
cancer-screening campaigns, growing medical tourism, and increasing
digitalization of radiology equipment are few other reasons that are projected
to grow the market by 2022.
Continuous
innovation and technological advancement make important factors for improving
performance that increases utility of digital mammography equipment. These
reasons have helped users to minimize radiation prescription without affecting
image quality. Other advancement that includes hybrid imaging which help in
creating anatomical images for efficient image analysis is expected to grow
market in the forecasted period. The growing popularity of 3-D mammography,
owing to its high level of accuracy, and better screening sensitivity, is
expected to fuel the market growth. Other similar technologies are contrast-
enhanced mammography, new algorithms for CAD C-View 2D, and breast
tomosynthesis.
The
digital mammography market is segmented by type into screening mammography and
diagnostic mammography. Screening mammography is primarily used in cases where
women have no early symptoms and need physical interpretation. Thus, here early
detection of breast cancer becomes utmost important and is usually done using
the X-ray. Diagnostic mammography is conducted after the initial sign of breast
cancer such as skin thickening, pain, nipple discharge, and change in breast
shape or size.
The
market is segmented by technology into film screen and digital. Screen film
mammography (SFM) uses high spatial resolution for producing cancer images.
Digital mammography uses photons that are converted to light and pass through a
device to produce display on a monitor. Primarily electronic x-ray detectors
are used in digital mammography and film cassettes are used in screen film
mammography.
The
market is segmented by region into North America, Latin America, Europe, Asia
Pacific, and Middle East. The North American region is accounted for highest
market share due to the high prevalence of breast cancer, and technical
advancements in the diagnostic imaging field. Particularly the US has the
market share of more than one third which is mainly because of the increasing
awareness of early stage cancer detection and improved healthcare facilities.
The Europe region is also accounted for high market share mainly due to the
high patient awareness and growing number of breast cancer patients. These
regions are expected to witness similar market growth trend over the forecasted
period.
The
Asia Pacific is projected to report fastest growth in the next seven years
mainly due to the increasing government spending in campaigning about early
detection of breast cancer, and increasing technological advancements.
Particularly countries such as India, China, Japan, Singapore and Russia, are
expected to account for highest market share in the region by 2022. This is
primarily due to the increasing patients of breast cancer, and increasing
investments in diagnostic & screening techniques. Middle East region is
relatively new in adopting the technology and thus reports to have high
potential markets.
Key
players in the digital mammography market are GE Healthcare, IMS
(Internazaional Medico Scientifica) srl, Hologic Inc., Planmed Oy, Toshiba
Medical Systems, Siemens Healthcare, and Koninklijke Philips N.V.
Comments
Post a Comment